Armstrong J - Search Results

1

Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.

O'Boyle G, Swidenbank I, Marshall H, Barker CE, Armstrong J, White SA, Fricker SP, Plummer R, Wright M, Lovat PE. O'Boyle G, et al. Among authors: armstrong j. Br J Cancer. 2013 Apr 30;108(8):1634-40. doi: 10.1038/bjc.2013.124. Epub 2013 Mar 28. Br J Cancer. 2013. PMID: 23538388 Free PMC article.

2

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

Flockhart RJ, Armstrong JL, Reynolds NJ, Lovat PE. Flockhart RJ, et al. Among authors: armstrong jl. Br J Cancer. 2009 Oct 20;101(8):1448-55. doi: 10.1038/sj.bjc.6605277. Epub 2009 Sep 1. Br J Cancer. 2009. PMID: 19724275 Free PMC article.

3

Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma.

Hill DS, Martin S, Armstrong JL, Flockhart R, Tonison JJ, Simpson DG, Birch-Machin MA, Redfern CP, Lovat PE. Hill DS, et al. Among authors: armstrong jl. Clin Cancer Res. 2009 Feb 15;15(4):1192-8. doi: 10.1158/1078-0432.CCR-08-2150. Clin Cancer Res. 2009. PMID: 19228725 Free PMC article.

4

Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.

Armstrong JL, Corazzari M, Martin S, Pagliarini V, Falasca L, Hill DS, Ellis N, Al Sabah S, Redfern CP, Fimia GM, Piacentini M, Lovat PE. Armstrong JL, et al. Clin Cancer Res. 2011 Apr 15;17(8):2216-26. doi: 10.1158/1078-0432.CCR-10-3003. Epub 2011 Jan 26. Clin Cancer Res. 2011. PMID: 21270111 Free article.

5

A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.

Hill DS, Robinson ND, Caley MP, Chen M, O'Toole EA, Armstrong JL, Przyborski S, Lovat PE. Hill DS, et al. Mol Cancer Ther. 2015 Nov;14(11):2665-73. doi: 10.1158/1535-7163.MCT-15-0394. Epub 2015 Sep 1. Mol Cancer Ther. 2015. PMID: 26330548 Free PMC article.

6

Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.

Wright TJ, McKee C, Birch-Machin MA, Ellis R, Armstrong JL, Lovat PE. Wright TJ, et al. Among authors: armstrong jl. Clin Exp Dermatol. 2013 Jun;38(4):421-3. doi: 10.1111/ced.12138. Epub 2013 Mar 27. Clin Exp Dermatol. 2013. PMID: 23530461

7

Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours.

Armstrong JL, Veal GJ, Redfern CP, Lovat PE. Armstrong JL, et al. Apoptosis. 2007 Mar;12(3):613-22. doi: 10.1007/s10495-006-0020-1. Apoptosis. 2007. PMID: 17216584

8

Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.

Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, Brown AM, Piacentini M, Birch-Machin MA, Redfern CP. Lovat PE, et al. Cancer Res. 2008 Jul 1;68(13):5363-9. doi: 10.1158/0008-5472.CAN-08-0035. Cancer Res. 2008. PMID: 18593938 Free PMC article.

9

The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.

Armstrong JL, Martin S, Illingworth NA, Jamieson D, Neilson A, Lovat PE, Redfern CP, Veal GJ. Armstrong JL, et al. Oncol Rep. 2012 Jan;27(1):293-8. doi: 10.3892/or.2011.1479. Epub 2011 Sep 29. Oncol Rep. 2012. PMID: 21964808

10

Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.

McKee CS, Hill DS, Redfern CP, Armstrong JL, Lovat PE. McKee CS, et al. Exp Dermatol. 2013 Nov;22(11):767-9. doi: 10.1111/exd.12254. Exp Dermatol. 2013. PMID: 24118207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,612 results

Search Page

Filters